SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-044294
Filing Date
2022-04-08
Accepted
2022-04-08 16:50:44
Documents
54
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F fwp-20211231x20f.htm   iXBRL 20-F 1940307
2 EXHIBIT 8.1 fwp-20211231xex8d1.htm EX-8.1 8329
3 EXHIBIT 12.1 fwp-20211231xex12d1.htm EX-12.1 16361
4 EXHIBIT 12.2 fwp-20211231xex12d2.htm EX-12.2 12312
5 EXHIBIT 13.1 fwp-20211231xex13d1.htm EX-13.1 6830
6 EXHIBIT 15.1 fwp-20211231xex15d1.htm EX-15.1 4008
  Complete submission text file 0001104659-22-044294.txt   7009808

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fwp-20211231.xsd EX-101.SCH 46357
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fwp-20211231_cal.xml EX-101.CAL 36870
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fwp-20211231_def.xml EX-101.DEF 190431
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwp-20211231_lab.xml EX-101.LAB 398316
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwp-20211231_pre.xml EX-101.PRE 295707
48 EXTRACTED XBRL INSTANCE DOCUMENT fwp-20211231x20f_htm.xml XML 1246960
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 22817653
SIC: 2834 Pharmaceutical Preparations